Early Data For GeoVax COVID-19 Vaccine Point To Efficacy In Immunocompromised Population

 
• By Alaric DeArment and Sarah Karlin-Smith
  
GeoVax presented early data for the GEO-CM04S1 COVID-19 vaccine • Source: Shutterstock

More from COVID-19

More from Scrip